Eukaryotic translation initiation factor 4E pseudogene 5 (EIF4EP5)

Eukaryotic translation initiation factor 4E pseudogene 5 (EIF4EP5) is classified as a pseudogene, meaning it is a genomic DNA sequence similar to a functional gene but generally regarded as nonfunctional due to mutations or lack of transcription/translation. EIF4EP5 is related by sequence to EIF4E, which is a cap-binding protein critically involved in eukaryotic mRNA translation initiation. However, unlike canonical EIF4E, EIF4EP5 does not encode a known functional protein and is not considered a therapeutic target, receptor, enzyme, transporter, or other functional molecular entity in drug discovery or human physiology. Therefore, there are no reported biological functions, molecular pathways, disease roles, or drug interactions associated with EIF4EP5[1][2].\n\nKey facts:\n- EIF4E, the functional gene family member, is involved in translation initiation and cancer but EIF4EP5 itself is a noncoding pseudogene and not a target for therapeutics[1][2].\n- No evidence supports EIF4EP5 as a biomarker or candidate for pharmaceutical intervention[1][2].\n\nTherefore, all structured entries regarding drug targeting, mechanism of action, or therapeutic relevance should be considered absent or not applicable for EIF4EP5.

Other names

EIF4E pseudogene 5eIF-4E pseudogene 5